Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Dec 20, 2012 van plew daniel p Officer Option Execute 2,050 16.80
May 6, 2013 van plew daniel p Officer Option Execute 32,950 16.80
Oct 25, 2012 van plew daniel p Officer Option Execute 30,000 21.92
Sep 17, 2013 van plew daniel p Officer Option Execute 52,500 16.80
Apr 27, 2012 van plew daniel p Officer Option Execute 35,216 20.90
May 22, 2014 van plew daniel p Officer Option Execute 11,200 21.25
Dec 12, 2013 yancopoulos george Officer Option Execute 9,599 260.44
Dec 17, 2012 yancopoulos george Officer Option Execute 10,369 109.29
Nov 30, 2011 yancopoulos george Officer Option Execute 200,000 28.01
May 6, 2013 yancopoulos george Officer Option Execute 192,308 13.00
Feb 15, 2012 yancopoulos george Officer Option Execute 133,332 8.50
Dec 16, 2008 yancopoulos george Officer Option Execute 100,000 7.41
Dec 3, 2009 yancopoulos george Officer Option Execute 100,000 8.77
Dec 16, 2014 yancopoulos george Officer Option Execute 3,264 30.63
Aug 27, 2014 yancopoulos george Officer Option Execute 5,720 314.31
Dec 19, 2013 yancopoulos george Officer Option Execute 4,705 21.25
Feb 11, 2014 yancopoulos george Officer Option Execute 189,463 9.49
Dec 19, 2012 yancopoulos george Officer Option Execute 50,846 9.49 - 21.92
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
Dec 22, 2010 brown michael s Director Disposition (Non Open Market) 5,000 n/a
Showing 401-420 of 974 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)